Compare AVD & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVD | SERA |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 75.2M |
| IPO Year | 1995 | 2021 |
| Metric | AVD | SERA |
|---|---|---|
| Price | $1.41 | $2.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | ★ 300.5K | 14.5K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $515,114,000.00 | $81,000.00 |
| Revenue This Year | $7.74 | $177.78 |
| Revenue Next Year | N/A | $755.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $1.61 | $1.56 |
| 52 Week High | $5.53 | $3.95 |
| Indicator | AVD | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 15.12 | 48.34 |
| Support Level | N/A | $1.97 |
| Resistance Level | $2.41 | $2.07 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 4.85 | 14.29 |
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.